05/17/2012 - 11:03am

People with higher levels of education and higher income have lower rates of many chronic diseases compared with those with less education and lower income levels, according to "Health, United States, 2011" — the government’s annual comprehensive report on Americans’ health released Wednesday.

05/16/2012 - 5:36pm

Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


05/16/2012 - 5:36pm

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

05/16/2012 - 1:34pm

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

05/15/2012 - 1:46pm

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

05/15/2012 - 10:02am

GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

05/15/2012 - 9:41am

The head of drug maker AstraZeneca will retire next month, the company said.

05/15/2012 - 9:30am

A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

05/15/2012 - 7:59am

Walgreens on Tuesday infused greater value into its Prescription Savings Club program, which now offers discounts on more than 8,000 brand-name and generic prescriptions, thanks to the inclusion of more than 700 "value-priced" generics, which retail as low as $12 for a 90-day supply.